PHARMACOKINETIC PROFILE OF METFORMIN HYDROCHLORIDE IN DRIED BLOOD SPOT OF HEALTHY SUBJECTS USING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY–PHOTODIODE ARRAY

Authors

  • Yahdiana Harahap Bioavailability/Bioequivalence Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok 16424, Indonesia.
  • Citra Dara Malia Bioavailability/Bioequivalence Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok 16424, Indonesia.
  • Sunarsih . Bioavailability/Bioequivalence Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok 16424, Indonesia.

DOI:

https://doi.org/10.22159/ijap.2018.v10s1.78

Keywords:

Dried blood spot, High-performance liquid chromatography, Metformin hydrochloride, Pharmacokinetic profile, Validation

Abstract

Objective: This study aimed to analyze the metformin hydrochloride in dried blood spot (DBS) sample and evaluate a pharmacokinetic profile in six
healthy subjects who administered 850-mg metformin hydrochloride in tablet using high-performance liquid chromatography–photodiode array
(HPLC–PDA).
Methods: Metformin analysis was performed on data of six healthy subjects who administered 850 mg of metformin hydrochloride as tablets. Blood
samples were taken at 12-time points at intervals of up to 12 h, and data were analyzed using HPLC–PDA.
Results: A linear calibration curve was obtained in the range of 25–5000 ng/mL, with r=0.9990. Pharmacokinetic profiles of metformin were obtained
using DBS samples from six healthy participants, with a Cmax of 347.3–416.22 ng/mL. The average tmax and t1/2 were obtained at 3 and 2 h, respectively,
and the area under the curve (AUC)0-t/AUC0-∞ ratio was >80% for all subjects.
Conclusion: The DBS biosampling technique can be developed for application in pharmacokinetic study of metformin HCl.

Downloads

Download data is not yet available.

References

Dipiro J, Dipiro CV, Wells BG, Scwinghammer TL. Pharmacotherapy

a Pathophysiologic Approach. 9th ed. United States: The McGraw-Hill

Companies, Inc.; 2015.

Muchid A. Pharmaceutical Care for Diabetes Mellitus. Jakarta:

Indonesian Ministry of Health; 2005.

Aburuz S, Millership J, McElnay J. Dried blood spot liquid

chromatography assay for therapeutic drug monitoring of metformin.

J Chromatogr B Analyt Technol Biomed Life Sci 2006;832:202-7.

Indonesian National Agency of Food and Drug Control. Regulation

from Head of No. HK.03.1.23.12.11.10217 about Drug Obligate

Equivalence Study Jakarta. Jakarta: Indonesian National Agency of

Food and Drug Control; 2011.

Tan MH, Alquraini H, Mizokami-Stout K, MacEachern M. Metformin:

From research to clinical practice. Endocrinol Metab Clin North Am

;45:819-43.

Earle RR, Bandaru KK, Lakshmi UA. Formulation and characterization

of sustained release coated matric granules of metformin hydrochloride.

Asian J Pharm Clin Res 2018;11:387-92.

Kotecha NC, Patel JK. Method development and validation of a

reversed-phase liquid chromatographic method for the simultaneous

estimation of selected anti diabetic drugs in the presence of their

degradation products. Asian J Pharm Clin Res 2018;11:345-52.

Bookya P, Raparla R, Sriamula HP, Tarrigopula S, Vanga S. Formulation

and evaluation of metformin hydrochloride sustained release oral

matrix tablets. Asian J Pharm Clin Res 2018;11:342-5.

Evans C, Arnold M, Bryan P, Duggan J, James CA, Li W, et al.

Implementing dried blood spot sampling for clinical pharmacokinetic

determinations: Considerations from the IQ consortium microsampling

working group. AAPS J 2015;17:292-300.

Center of Drug Evaluation and Research. Metformin Hydrochloride

Tablets. United States: Food and Drug Administration; 2002.

Scherf-Clavel M, Högger P. Analysis of metformin, sitagliptin and

creatinine in human dried blood spots. J Chromatogr B Analyt Technol

Biomed Life Sci 2015;997:218-28.

Wilhelm AJ, den Burger JC, Swart EL. Therapeutic drug monitoring

by dried blood spot: Progress to date and future directions. Clin

Pharmacokinet 2014;53:961-73.

Alshishani A, Makahleh A, Yap HF, Gubartallah EA, Salhimi SM, Saad B,

et al. Ion-pair vortex assisted liquid-liquid microextraction with back

extraction coupled with high performance liquid chromatography-UV for

the determination of metformin in plasma. Talanta 2016;161:398-404.

Evans G. A Handbook of Bioanalysis and Drug Metabolism. United

States of America: CRC Press; 2014.

Porta V, Schramm S, Kano E, Koono E, Armando Y, Fukuda K, et al.

HPLC-UV determination of metformin in human plasma for application

in pharmacokinetics and bioequivalence studies. J Pharm Biomed Anal

;46:143-7.

Sharma A, Jaiswal S, Shukla M, Lal J. Dried blood spots: Concepts,

present status, and future perspectives in bioanalysis. Drug Test Anal

;6:399-414.

Published

20-12-2018

How to Cite

Harahap, Y., Malia, C. D., & ., S. (2018). PHARMACOKINETIC PROFILE OF METFORMIN HYDROCHLORIDE IN DRIED BLOOD SPOT OF HEALTHY SUBJECTS USING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY–PHOTODIODE ARRAY. International Journal of Applied Pharmaceutics, 10(1), 354–357. https://doi.org/10.22159/ijap.2018.v10s1.78

Issue

Section

Original Article(s)